Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01874223 · ClinicalTrials.gov registry record

Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With IPF

A clinical trial, sponsored by Stanford University.

Completed
Registry status
40
Enrollment target

NCT01874223: Completed study, sponsored by Stanford University.

NCT01874223 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 40 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01874223 has completed, sponsored by Stanford University.

COMPLETED
Registry status
40 participants
Enrollment target

Study Summary

The purpose of this study is to test cough, dyspnea (shortness of breath), and quality of life (QOL) questionnaires for their accuracy, sensitivity, and ability to reliably measure the severity of cough, breathlessness, and changes in cough and disease-related quality of life over time in Idiopathic Pulmonary Fibrosis (IPF) patients. These questionnaires have been used in other types of disease, but have not all been tested and validated in patients with cough due to IPF. Our hypothesis is that worsening of cough, dyspnea, and cough-related QOL questionnaire scores will correlate with physiologic markers of IPF severity and worsening of disease. Written, valid questionnaires measuring cough, dyspnea, and QOL are important to assess the benefit of investigational drugs under development to treat patients with IPF.

Primary Outcome

Change scores for the LCQ cough-related quality of life instrument will be correlated with changes in pulmonary function tests

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2013-06
Est. Completion 2018-11-04
Stanford University

1,744 total trials

What the finished NCT01874223 record still lists

NCT01874223 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 40 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT01874223 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01874223 about?

NCT01874223 is a clinical study titled "Prospective Validation of Cough, Dyspnea, and Quality of Life Questionnaires in Patients With IPF". The purpose of this study is to test cough, dyspnea (shortness of breath), and quality of life (QOL) questionnaires for their accuracy, sensitivity, and ability to reliably measure the severity of cough, breathlessness, and changes in cough and disease-related quality of life over time in Idiopathic...

What is the current status of trial NCT01874223?

This trial is currently completed. The enrollment target is 40 participants. The study started on 2013-06. Estimated completion is 2018-11-04.

Who is sponsoring clinical trial NCT01874223?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01874223, the US trial registry maintained by the National Library of Medicine. NCT01874223 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.